Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA revision label on the study page was updated from v3.6.2 to v3.6.3, indicating an administrative update to the ClinicalTrials.gov page. It does not alter the study details, enrollment, or eligibility.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now displays revision v3.6.2, replacing the previous v3.6.0. This indicates a page-build update rather than a change to study details.SummaryDifference0.0%

- Check33 days agoChange DetectedNew navigation and help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment status now indicates no longer looking for participants. A formatting adjustment for Intervention/Treatment and an update to the page revision (v3.6.0) are also included.SummaryDifference0.4%

- Check40 days agoChange DetectedThe page’s revision label updates from v3.5.4 to v3.5.5, signaling a backend or frontend update. This change reflects an upgrade to the page framework rather than new or altered study information.SummaryDifference0.0%

- Check62 days agoChange DetectedA new revision label, v3.5.4, appears on the page, indicating a small update to the page version. This updates the page version without altering the study details or data shown.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.5.3 was added, replacing the previous Revision: v3.5.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.